Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,674,000 | 13,023,000 | 6,687,000 | 5,552,000 | 3,709,000 |
| Marketable Securities | 773,000 | 839,000 | 2,535,000 | 2,567,000 | 1,366,000 |
| Receivables | 8,180,000 | 8,275,000 | 9,902,000 | 10,051,000 | 10,323,000 |
| Inventories | 6,226,000 | 6,093,000 | 7,267,000 | 6,744,000 | 5,930,000 |
| Other current assets | 2,992,000 | 9,331,000 | 4,151,000 | 3,090,000 | 2,756,000 |
| TOTAL | $22,845,000 | $37,561,000 | $30,542,000 | $28,004,000 | $24,084,000 |
| Non-Current Assets | |||||
| PPE Net | 15,982,000 | 15,983,000 | 18,197,000 | 16,939,000 | 15,627,000 |
| Investments And Advances | 17,780,000 | 10,152,000 | 10,748,000 | 9,957,000 | 9,560,000 |
| Intangibles | 65,391,000 | 53,143,000 | 58,867,000 | 61,421,000 | 61,912,000 |
| Other Non-Current Assets | 9,558,000 | 8,548,000 | 7,900,000 | 7,870,000 | 6,313,000 |
| TOTAL | $108,711,000 | $87,826,000 | $95,712,000 | $96,187,000 | $93,412,000 |
| Total Assets | $131,556,000 | $125,387,000 | $126,254,000 | $124,191,000 | $117,496,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,604,000 | 6,612,000 | 6,776,000 | 5,945,000 | 6,374,000 |
| Accounts payable and accrued liabilities | 5,668,000 | 5,419,000 | 6,148,000 | 5,593,000 | 4,989,000 |
| Other current liabilities | 10,719,000 | 10,448,000 | 10,935,000 | 10,443,000 | 10,079,000 |
| TOTAL | $23,708,000 | $26,973,000 | $26,368,000 | $24,051,000 | $23,148,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 16,327,000 | 13,799,000 | 11,242,000 | 13,781,000 | 13,855,000 |
| Other Non-Current Liabilities | 8,033,000 | 7,602,000 | 7,151,000 | 9,697,000 | 7,660,000 |
| TOTAL | $30,726,000 | $27,570,000 | $25,414,000 | $30,877,000 | $28,408,000 |
| Total Liabilities | $54,434,000 | $54,543,000 | $51,782,000 | $54,928,000 | $51,556,000 |
| Shareholders' Equity | |||||
| Common Shares | 991,000 | 1,001,000 | 1,001,000 | 1,001,000 | 1,016,000 |
| Retained earnings | 80,379,000 | 69,868,000 | 73,431,000 | 68,228,000 | 64,949,000 |
| Other shareholders' equity | -4,147,000 | 78,000 | 129,000 | 126,000 | 96,000 |
| TOTAL | $77,122,000 | $70,844,000 | $74,472,000 | $69,263,000 | $65,940,000 |
| Total Liabilities And Equity | $131,556,000 | $125,387,000 | $126,254,000 | $124,191,000 | $117,496,000 |